Development and validation of a multidimensional questionnaire for evaluating quality of life in melasma (HRQ-melasma)*
Lido
5922
Vezesque se leu este artigo
2719
Total PDF
3203
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 59 | 30 | 89 |
| 2025 5 | 142 | 61 | 203 |
| 2025 4 | 129 | 38 | 167 |
| 2025 3 | 127 | 39 | 166 |
| 2025 2 | 141 | 80 | 221 |
| 2025 1 | 113 | 45 | 158 |
| 2024 12 | 95 | 50 | 145 |
| 2024 11 | 104 | 46 | 150 |
| 2024 10 | 104 | 75 | 179 |
| 2024 9 | 133 | 80 | 213 |
| 2024 8 | 118 | 101 | 219 |
| 2024 7 | 134 | 110 | 244 |
| 2024 6 | 97 | 62 | 159 |
| 2024 5 | 87 | 62 | 149 |
| 2024 4 | 94 | 77 | 171 |
| 2024 3 | 76 | 59 | 135 |
| 2024 2 | 80 | 76 | 156 |
| 2024 1 | 48 | 44 | 92 |
| 2023 12 | 54 | 54 | 108 |
| 2023 11 | 55 | 69 | 124 |
| 2023 10 | 38 | 59 | 97 |
| 2023 9 | 51 | 55 | 106 |
| 2023 8 | 39 | 37 | 76 |
| 2023 7 | 66 | 32 | 98 |
| 2023 6 | 42 | 31 | 73 |
| 2023 5 | 38 | 20 | 58 |
| 2023 4 | 43 | 13 | 56 |
| 2023 3 | 55 | 43 | 98 |
| 2023 2 | 37 | 31 | 68 |
| 2023 1 | 34 | 38 | 72 |
| 2022 12 | 42 | 59 | 101 |
| 2022 11 | 55 | 50 | 105 |
| 2022 10 | 51 | 38 | 89 |
| 2022 9 | 26 | 53 | 79 |
| 2022 8 | 31 | 40 | 71 |
| 2022 7 | 32 | 38 | 70 |
| 2022 6 | 20 | 40 | 60 |
| 2022 5 | 27 | 48 | 75 |
| 2022 4 | 49 | 46 | 95 |
| 2022 3 | 33 | 51 | 84 |
| 2022 2 | 20 | 41 | 61 |
| 2021 1 | 24 | 47 | 71 |
| 2021 12 | 28 | 46 | 74 |
| 2021 11 | 32 | 44 | 76 |
| 2021 10 | 38 | 65 | 103 |
| 2021 9 | 29 | 47 | 76 |
| 2021 8 | 30 | 40 | 70 |
| 2021 7 | 27 | 48 | 75 |
| 2021 6 | 28 | 34 | 62 |
| 2021 5 | 24 | 35 | 59 |
| 2021 4 | 28 | 173 | 201 |
| 2021 3 | 45 | 10 | 55 |
| 2021 2 | 12 | 2 | 14 |
| 2020 1 | 32 | 4 | 36 |
| 2020 12 | 7 | 3 | 10 |
Mostrar tudo
